Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [41] Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer
    Ramalingam, Suresh S.
    Blais, Normand
    Mazieres, Julien
    Reck, Martin
    Jones, C. Michael
    Juhasz, Erzsebet
    Urban, Laszlo
    Orlov, Sergey
    Barlesi, Fabrice
    Kio, Ebenezer
    Keiholz, Ulrich
    Qin, Qin
    Qian, Jiang
    Nickner, Caroline
    Dziubinski, Juliann
    Xiong, Hao
    Ansell, Peter
    McKee, Mark
    Giranda, Vincent
    Gorbunova, Vera
    CLINICAL CANCER RESEARCH, 2017, 23 (08) : 1937 - 1944
  • [42] Carboplatin plus Weekly Paclitaxel Treatment in Non-small Cell Lung Cancer Patients with Interstitial Lung Disease
    Shukuya, T.
    Ishiwata, T.
    Hara, M.
    Muraki, K.
    Shibayama, R.
    Koyama, R.
    Takahashi, K.
    ANTICANCER RESEARCH, 2010, 30 (10) : 4357 - 4361
  • [43] Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
    Sandler, Alan
    Yi, Jing
    Dahlberg, Suzanne
    Kolb, Margaret M.
    Wang, Lisa
    Hambleton, Julie
    Schiller, Joan
    Johnson, David H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1416 - 1423
  • [44] Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer
    Randall, J. Michael
    Bharne, Anjali A.
    Bazhenova, Lyudmila A.
    JOURNAL OF THORACIC DISEASE, 2013, 5 (02) : E53 - E57
  • [45] Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer
    Greco, FA
    LUNG CANCER, 2001, 34 : S53 - S56
  • [46] Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
    Reck, Martin
    Shankar, Geetha
    Lee, Anthony
    Coleman, Shelley
    McCleland, Mark
    Papadimitrakopoulou, Vassiliki A.
    Socinski, Mark A.
    Sandler, Alan
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 125 - 136
  • [47] A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer
    Shimizu, Tetsuo
    Nakagawa, Yoshiko
    Asai, Yasuo
    Tsujino, Ichirou
    Takahashi, Noriaki
    Gon, Yasuhiro
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (07) : 3079 - 3087
  • [48] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
  • [49] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
  • [50] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
12345